- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06058975
National Retrospective Study of Duodenal Trauma (TRAUMADUOD)
Duodenal injuries remain rare among abdominal trauma, concerning less than 5 % of cases. However, due to its central location, it is most commonly associated with multiple organs lesions, with the main three organs being the liver, the colon and the pancreas. Additionally, the penetrating mechanism is four times more common than blunt trauma and the most common duodenal site of injury is the second portion (36 %), the least being the first duodenum (13 %). These particularities generate a high morbidity, ranging from 22 to 27.1 %, and a mortality still as high as 5.3 to 30 % today. When facing it, surgeons are usually challenged in their strategy. Indeed, when surgery is required, different options can be chosen depending on the grade of the lesion and the involvement of the papilla and/or other organs. Primary repairs, duodenal diverticulization, pyloric exclusion, gastrojejunostomy, retrograde duodenostomy, distal feeding tube, or even resection and Whipple procedures, have all been described. Since the classification of the American Association for the surgery of trauma (AAST), most studies stratified their management as such: drainage only or primary repair for grade 1 and 2, jejunostomy and/or pyloric exclusion for grade 3, Whipple for grade 4 or 5. However, reviews of the literature aren't clear if this decisional tree is in correlation with lower morbidities, and often different procedures have been reported for the same grade. The escalation of technical exclusions among severe grades became controversial. As an example, pyloric exclusion has been criticized in its preventive role of protecting the suture, being useless at least, or even worse at times. Thus, in the recent years, the management has been focused towards minimization. Indeed, in the retrospective review of the Pan-American trauma society primary repair alone was performed in 80 % of cases, all grades comprised. Although mortality was high, duodenal suture line leak was statistically lower among survivors over every grade.
To clear the situation, prospective studies are difficult if not impossible in such context. Thus, The investigators propose this national benchmark, to retrospectively review in France the management of duodenal trauma, depending on the grade, and its associated morbidity.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Damien MASSALOU
- Phone Number: +33 0492033313
- Email: massalou.d@chu-nice.Fr
Study Contact Backup
- Name: Sébastien FREY
- Email: frey.s@chu-nice.fr
Study Locations
-
-
Alpes Maritimes
-
Nice, Alpes Maritimes, France, 06000
- Recruiting
- CHU de Nice
-
Principal Investigator:
- Damien MASSALOU
-
Contact:
- Sébastien FREY
- Email: frey.s@chu-nice.fr
-
Contact:
- Damien MASSALOU
- Phone Number: +33 0492033312
- Email: massalou.d@chu-nice.fr
-
Sub-Investigator:
- Sébastien FREY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with duodenal trauma,
- older than 18 years old.
Exclusion Criteria:
- pregnancy
- previous duodenal surgery.
- Associated surrounding organs trauma, was not an exclusion criterion, but duodenal trauma must have been one of the main injuries.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall mortality
Time Frame: 1 month after trauma
|
Study mortality is overall mortality, not specific to abdominal trauma.
It corresponds to grade 5 of the Clavien-Dindo classification.
|
1 month after trauma
|
Specific mortality
Time Frame: 1 month after trauma
|
Specific mortality is the mortality due to abdominal trauma, including abdominal compartment syndrome, coagulopathy, hemorrhage, multi-organ failure, etc.
It excludes brain death, mortality due to trauma of other body regions.
It corresponds to grade 5 of the Clavien-Dindo classification.
|
1 month after trauma
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severe morbidity
Time Frame: 3 months after trauma
|
Morbidity will be recorded according to the Clavien-Dindo classification.
We will study overall morbidity and severe morbidity (stages 3 and 4).
As a reminder, stage 1 corresponds to a simple deviation from the operative course, stage 2 to medical treatment, stage 3 to interventional management (with or without general anaesthesia), and stage 4 to organ or multi-visceral failure.
|
3 months after trauma
|
Kind of treatment: medical, endoscopic or surgical
Time Frame: The first 3 months after trauma
|
We will record the type of initial treatment performed, whether non-operative, endoscopic, laparoscopic or by laparotomy. We will collect the results of this initial treatment, including the possibility of complementary treatments, whatever the approach used and any failures. Non-operative management is defined as an exclusive medical attitude, including diagnostic imaging, but without interventional procedures. Interventional radiology management is defined as a percutaneous procedure performed under the control of diagnostic imaging, e.g. ultrasound- or scan-guided puncture of a collection. Endoscopic management includes diagnostic or therapeutic endoscopy, for example: endoscopic realignment of the Wirsung duct, puncture of a pancreatic pseudocyst, duodenal stenting, etc. Surgical management is defined as any surgical procedure requiring an opening of the abdomen. The approach is indicated as laparotomy or laparoscopy. |
The first 3 months after trauma
|
type of injury of the duodenum
Time Frame: no later than the 7th day after the trauma
|
The surgeon is free to describe the lesions, in order to gather as much information as possible on the location of the lesion, its size, etc. We will also ask investigators to describe the lesions encountered, using the classification established by the AAST (American Association for the Surgery of Trauma). |
no later than the 7th day after the trauma
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 23Urgences02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Duodenal Diverticulization
-
University Hospital, Strasbourg, FranceRecruitingCongenital Duodenal AtresiaFrance
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)Completed
-
Boston Children's HospitalRecruitingDuodenal AtresiaUnited States
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)Completed
-
The Catholic University of KoreaUnknown
-
Boryung Pharmaceutical Co., LtdCompletedGastric or Duodenal UlcerKorea, Republic of
-
Boryung Pharmaceutical Co., LtdCompleted
-
Sihuan Pharmaceutical Holdings Group Ltd.Unknown
-
Odense University HospitalCompleted
-
The Third Xiangya Hospital of Central South UniversityLivzon Pharmaceutical Group Inc.; Yung Shin Pharm. Ind. Co., Ltd.CompletedDuodenal Ulcer Due to Helicobacter PyloriChina
Clinical Trials on Observational
-
American Gastroenterological AssociationUniversity of Pennsylvania; University of California, San Diego; University of... and other collaboratorsRecruitingClostridium Difficile Infection | Gut Microbiome | Fecal Microbiota TransplantationUnited States, Canada
-
University of MinnesotaAgency for Healthcare Research and Quality (AHRQ)RecruitingTraumatic Brain Injury | Venous ThromboembolismUnited States
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium
-
St. Louis UniversityActive, not recruitingVertebral Artery StenosisUnited States
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
AstraZenecaRecruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States